Skip to main content

Table 2 Outcomes of Patients during Follow-Up

From: Readmissions, revisions, and mortality after treatment for proximal humeral fractures in three large states

  Initial Treatment  
Non-Operative
121,411
ORIF
8994
Arthroplasty
4006
p-valueΠ
Revision surgerya:
 ORIF 5410 (4.5%) 225 (2.5%) 73 (1.8%) 0.009
 Arthroplasty 3747 (3.1%) 369 (4.1%) 217 (5.4%) 0.66
All-cause mortality while in-patient 11,876 (9.8%) 787 (8.8%) 401 (10.0%) 0.003
Reasons for readmission  
Device complications N/A 475 (5.3%) 270 (6.7%) < 0.0001
Wound complications N/A 172 (1.9%) 73 (1.8%) 0.0002
Pulmonary embolism 30 (0.02%) * * 0.004
Deep venous thrombosis of lower extremity 1495 (1.2%) 130 (1.4%) 79 (2.0%) 0.33
Venous embolism or thrombosis of other site 127 (0.10%) 15 (0.17%) * 0.22
Cardiac complications 60 (0.05%) * * 0.88
Cardiac rhythm conversion 2405 (2.0%) 150 (1.7%) 89 (2.2%) 0.02
Unspecified septicemia 7131 (5.9%) 491 (5.5%) 265 (6.6%) 0.01
  1. ORIF open reduction and internal fixation
  2. SD standard deviation
  3. * Value < 10
  4. Π p-values of non-operative vs. ORIF vs. arthroplasty as treatment
  5. aPercentages based on initial cohort of subjects